Sonendo Inc (SONX) USD0.001

Sell:$1.14Buy:$1.14No change

Prices delayed by at least 15 minutes
Sell:$1.14
Buy:$1.14
Change:No change
Prices delayed by at least 15 minutes
Sell:$1.14
Buy:$1.14
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to dissolve tissue and bacteria using minimal or no instrumentation. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.

Key people

Bjarne Bergheim
President, Chief Executive Officer, Director
John J. Bostjancic
Chief Financial Officer
John P. Mcgaugh
Senior Vice President - Operations
Chris Guo
Vice President - Finance, Corporate Controller
Anthony P. Bihl
Non-Executive Independent Chairman of the Board
Carolyn D. Beaver
Independent Director
Olav Bergheim
Independent Director
Raj Pudipeddi
Independent Director
Click to see more

Key facts

  • EPIC
    SONX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US8354312063
  • Market cap
    $487,240.00
  • Employees
    131
  • Shares in issue
    427,401.00
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.